Intera Oncology Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
42
- Latest Deal Type
-
M&A
- (Announced)
- Investors
-
1
Intera Oncology General Information
Description
Developer of a medical device designed to substantially improve survival and standard of care for colorectal cancer and cholangiocarcinoma patients. The company's device offers a simple continuous flow pump to deliver chemotherapy directly to the liver to stop the development of metastases in the liver, enabling patients to fight cancer and treat liver metastases.
Contact Information
Website
www.interaoncology.comCorporate Office
- 180 Wells Avenue
- Suite 300A
- Newton, MA 02459
- United States
Corporate Office
- 180 Wells Avenue
- Suite 300A
- Newton, MA 02459
- United States
Intera Oncology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 24-Nov-2024 | Announced | Generating Revenue | |||
| 3. Early Stage VC (Series A3) | 10-Aug-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A2) | 14-Aug-2020 | $884K | $3.29M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 27-Jun-2019 | $2.4M | $2.4M | Completed | Startup |
Intera Oncology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 1,857,142 | $0.001000 | $3.5 | $3.5 | 1x | $3.5 | 29.39% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Intera Oncology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Intera Oncology Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arkin Capital | Venture Capital | Minority |
Intera Oncology FAQs
-
When was Intera Oncology founded?
Intera Oncology was founded in 2019.
-
Where is Intera Oncology headquartered?
Intera Oncology is headquartered in Newton, MA.
-
What is the size of Intera Oncology?
Intera Oncology has 42 total employees.
-
What industry is Intera Oncology in?
Intera Oncology’s primary industry is Therapeutic Devices.
-
Is Intera Oncology a private or public company?
Intera Oncology is a Private company.
-
What is Intera Oncology’s current revenue?
The current revenue for Intera Oncology is .
-
How much funding has Intera Oncology raised over time?
Intera Oncology has raised $3.7M.
-
Who are Intera Oncology’s investors?
Arkin Capital has invested in Intera Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
